Tag: Epilepsy

Zydus Lifesciences gets FDA final approval for Oxcarbazepine tablets

businessnewstoday- July 4, 2023

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to produce and sell Oxcarbazepine tablets in strengths of 150 mg, ... Read More

Granules India gets FDA approval for generic epilepsy drug Levetiracetam

businessnewstoday- June 16, 2023

Granules India has announced its receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam ... Read More

Zydus Lifesciences subsidiary launches Trokendi XR generic in US

businessnewstoday- January 8, 2023

Zydus Lifesciences (previously Cadila Healthcare) said that its subsidiary Zydus Pharmaceuticals (USA) Inc. has launched Topiramate Extended-Release Capsules in the US. The launch follows the ... Read More

Lupin gets FDA approval for Vigabatrin for Oral Solution USP, 500 mg

pallavi123- March 12, 2022

Lupin Limited said that it has secured approval for Vigabatrin for Oral Solution USP, 500 mg, an anti-epileptic drug, from the US Food and Drug ... Read More

Zydus Cadila gets FDA approval to market Vigabatrin Tablets 500mg

pallavi123- January 20, 2022

Zydus (Cadila Healthcare) has secured final approval from the US Food and Drug Administration (FDA) to market Vigabatrin Tablets in the strength of 500mg. Vigabatrin ... Read More

MGC Pharmaceuticals signs supply deal with AMC for phytomedicine products

pallavi123- August 26, 2021

MGC Pharmaceuticals, a developer of phytocannabinoid-derived medicines, has signed a $24 million supply and distribution deal with US-based AMC Holdings. The deal is for the ... Read More

Zydus Cadila secures tentative approval from FDA for Brivaracetam Tablets

pallavi123- June 20, 2021

Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) to market Brivaracetam ... Read More

Jazz Pharmaceuticals to acquire Epidiolex developer GW Pharmaceuticals for $7.2bn

pharmanewsdaily- February 3, 2021

Irish biopharma company Jazz Pharmaceuticals has agreed to acquire British pharma company GW Pharmaceuticals in a cash-cum-stock deal worth $7.2 billion. Upon closing of the ... Read More

Zogenix bags Fintepla FDA approval for Dravet syndrome treatment

pharmanewsdaily- June 26, 2020

Fintepla FDA approval : Zogenix has bagged approval from the US Food and Drug Administration (FDA) for Fintepla (fenfluramine) oral solution, CIV for the treatment ... Read More

Taro recalls lot of Lamotrigine tablets in US due to contamination

pharmanewsdaily- January 12, 2020

Taro Pharmaceuticals U.S.A. has issued to recall of a lot of Lamotrigine 100 mg tablets owing to cross-contamination with a trace of another drug substance ... Read More